LETTERS FOR ISSUE ON
|
|
|
- Debra Cross
- 5 years ago
- Views:
Transcription
1 S FOR ISSUE ON LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. BIOMATRIX HEALTHCARE C/O. SHREE KRISHNA KESHAV, GUJARAT APPROVAL 02 M/S. AISHWARYA LIFESCIENCES, H.P , APPROVAL 03 M/S. EUROLIFE HEALTHCARE (P) LTD., HARIDWAR APPROVAL VACCINE DIVISION S. NO. COMPANY NAME DY. NO. STATUS 1 M/S DR, REDDY LABORATORIES LTD APPROVAL 2 M/S BHARAT SERUM AND VACCINE LTD 3 M/S HAFFKINE BIOPHARMACEUTICAL CORP LTD 10006, (FTS NO) INFORMATION (FTS NO) INFORMATION 4 SERUM INSTITUTE OF INDIA (FTS NO) INFORMATION 5 VINS BIOPRODUCTS LTD (FTS NO) INFORMATION 6 M/S VIRCHOW BIOTECH PVT, LTD (FTS NO) INFORMATION 7 M/S PREMIUM SERUM AND VACCINE PVT, LTD (FTS NO) INFORMATION
2 MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. BOSTON SCIENTIFIC INDIA PVT. LTD. FTS-8918 APPROVAL (F-RC) 2. M/S. BOSTON SCIENTIFIC INDIA PVT. LTD. FTS-8918 APPROVAL (F-IL) 3. M/S. MYOVATEC SURGICAL SYSTEMS PVT. LTD APPROVAL (R-IL) 4. M/S. JOHNSON & JOHNSON LTD DIAGNOSTIC DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. VISHAT DIAGNOSTICS PVT. LTD APPROVAL (IL) 2. M/S. MERIL DIAGNOSTICS PVT. LTD APPROVAL (E-IL) 3. M/S. TRANSASIA BIO MEDICALS LTD APPROVAL (E-IL) 4. M/S. MERIL DIAGNOSTICS PVT. LTD APPROVAL (TL) 5. M/S. VISHAT DIAGNOSTICS PVT. LTD APPROVAL (TL) 6. M/S. VISHAT DIAGNOSTICS PVT. LTD APPROVAL (TL) 7. M/S. BHAT BIO-TECH INDIA (P) LTD THE DRUGS CONTROLLER, BANGALORE. THE DDC (I), BANGALORE. 8. M/S. NUCLEUS INC ALL PORT OFFICES OF CSDCO.
3 WRITTEN CONFIRMATION S. NO FIRM NAME TYPE OF 1. M/S NOSCH LABS PVT. LTD., AP WC 2. M/S MYLAN LABORATORIESLTD. AP WC BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT. LTD., NAVI MUMBAI M/S. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD., HYDERABAD M/S. ALEMBIC PHARMACEUTICALS LTD., VADODARA M/S. ALEMBIC PHARMACEUTICALS LTD., VADODARA M/S. ALEMBIC PHARMACEUTICALS LTD., VADODARA M/S. ALKEM LABORATORIES LTD., TALOJA , TAL: PANVEL, DIST: RAIGAD 7. M/S. ALKEM LABORATORIES LTD., TALOJA , TAL: PANVEL, DIST: RAIGAD 8. M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., HYDERABAD M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA LTD., CLARIFICATION TEST LICENCE APPROVAL TEST LICENCE TEST LICENCE CLARIFICATION APPROVAL AMENDMENT AMENDMENT
4 HYDERABAD M/S. APOTEX RESEARCH PVT. LTD., BANGALORE M/S. APOTEX RESEARCH PVT. LTD., BANGALORE M/S. APOTEX RESEARCH PVT. LTD., BANGALORE M/S. AXIS CLINICAL LTD., HYDERABAD M/S. AXIS CLINICAL LTD., HYDERABAD M/S. AZIDUS LABORATORIES LTD., CHENNAI M/S. CADILA HEALTHCARE LTD., AHMEDABAD M/S. CADILA HEALTHCARE LTD., AHMEDABAD APPROVAL TEST LICENCE TEST LICENCE 9934 TEST LICENCE 9195 TEST LICENCE APPROVAL APPROVAL APPROVAL 18. M/S. CIPLA LIMITED, MUMBAI AMENDMENT 19. M/S. CIPLA LIMITED, MUMBAI APPROVAL 20. M/S. CIPLA LIMITED, MUMBAI TEST LICENCE 21. M/S. CIPLA LIMITED, MUMBAI TEST LICENCE 22. M/S. CLIANTHA RESEARCH LIMITED, 23. M/S. CLIANTHA RESEARCH LIMITED, 24. M/S. CLIANTHA RESEARCH LIMITED, 25. M/S. CLIANTHA RESEARCH LIMITED, 26. M/S. CLIANTHA RESEARCH LIMITED, CLARIFICATION APPROVAL APPROVAL APPROVAL APPROVAL
5 27. M/S. CLIANTHA RESEARCH LIMITED, 28. M/S. CLIANTHA RESEARCH LIMITED, 29. M/S. EMCURE PHARMACEUTICALS LIMITED, PUNE M/S. EMCURE PHARMACEUTICALS LIMITED, PUNE M/S. EMCURE PHARMACEUTICALS LIMITED, PUNE M/S. EMCURE PHARMACEUTICALS LIMITED, PUNE M/S. ETHICS BIO LAB PVT. LTD., PALLIKARANAI, CHENNAI M/S. GLENMARK GENERICS LTD., NAVI 35. M/S. GLENMARK GENERICS LTD., NAVI 36. M/S. GLENMARK GENERICS LTD., NAVI 37. M/S. GLENMARK GENERICS LTD., NAVI 38. M/S. GLENMARK GENERICS LTD., NAVI 39. M/S. GLENMARK GENERICS LTD., NAVI 40. M/S. GLENMARK GENERICS LTD., NAVI 41. M/S. GLENMARK GENERICS LTD., NAVI 42. M/S. HETERO LABS LTD., HYDERABAD APPROVAL APPROVAL AMENDMENT AMENDMENT APPROVAL TEST LICENCE APPROVAL CLARIFICATION CLARIFICATION AMENDMENT APPROVAL TEST LICENCE TEST LICENCE TEST LICENCE TEST LICENCE APPROVAL 43. M/S. HETERO LABS LTD., HYDERABAD APPROVAL
6 M/S. HETERO LABS LTD., HYDERABAD M/S. HETERO LABS LTD., HYDERABAD M/S. JUBILANT GENERICS LTD., NOIDA , UP 47. M/S. JUBILANT GENERICS LTD., NOIDA , UP 48. M/S. JUBILANT GENERICS LTD., NOIDA , UP 49. M/S. LAMBDA THERAPEUTIC 50. M/S. LAMBDA THERAPEUTIC 51. M/S. LAMBDA THERAPEUTIC 52. M/S. LAMBDA THERAPEUTIC 53. M/S. LAMBDA THERAPEUTIC 54. M/S. LAMBDA THERAPEUTIC 55. M/S. LOTUS LABS PVT. LTD., BANGALORE M/S. LOTUS LABS PVT. LTD., BANGALORE M/S. LOTUS LABS PVT. LTD., BANGALORE M/S. LOTUS LABS PVT. LTD., BANGALORE M/S. LOTUS LABS PVT. LTD., BANGALORE TEST LICENCE TEST LICENCE CLARIFICATION APPROVAL APPROVAL APPROVAL APPROVAL TEST LICENCE TEST LICENCE TEST LICENCE TEST LICENCE APPROVAL CLARIFICATION APPROVAL APPROVAL APPROVAL
7 60. M/S. LOTUS LABS PVT. LTD., CHENNAI M/S. LUPIN LIMITED (RESEARCH PARK), 62. M/S. LUPIN LIMITED (RESEARCH PARK), 63. M/S. LUPIN LIMITED (RESEARCH PARK), 64. M/S. LUPIN LIMITED (RESEARCH PARK), 65. M/S. LUPIN LIMITED (RESEARCH PARK), 66. M/S. LUPIN LIMITED (RESEARCH PARK), 67. M/S. LUPIN LIMITED (RESEARCH PARK), 68. M/S. LUPIN LIMITED (RESEARCH PARK), 69. M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI (EAST), MUMBAI M/S. MACLEODS PHARMACEUTICALS LTD., ANDHERI (EAST), MUMBAI M/S. MANIPAL ACUNOVA LTD., BANGALORE M/S. MANKIND PHARMA LIMITED, NEW DELHI M/S. MICRO THERAPEUTIC RESEARCH LABS PVT. LTD., COIMBATORE M/S. RA CHEM PHARMA LTD., BALANAGAR, HYDERABAD M/S. RA CHEM PHARMA LTD., BALANAGAR, HYDERABAD APPROVAL CLARIFICATION APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL CLARIFICATION APPROVAL CLARIFICATION APPROVAL 3414 APPROVAL CLARIFICATION TEST LICENCE 76. M/S. RA CHEM PHARMA LTD., TEST LICENCE
8 BALANAGAR, HYDERABAD M/S. RA CHEM PHARMA LTD., BALANAGAR, HYDERABAD M/S. RAPTIM RESEARCH LTD., NAVI MUMBAI M/S. RAPTIM RESEARCH LTD., NAVI MUMBAI M/S. RELIANCE LIFE SCIENCES PVT. LTD., NAVI MUMBAI M/S. SITEC LABS PVT LTD, NAVI MUMBAI M/S. SITEC LABS PVT LTD, NAVI MUMBAI M/S. STRIDES ARCOLAB LTD., BANGALORE M/S. SUN PHARMA ADVANCED RESEARCH COMPANY LTD., VADODARA M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. SUN PHARMACEUTICAL INDUSTRIES LTD., VADODARA M/S. SYNCHRON RESEARCH SERVICES PVT. LTD., AHMEDABAD M/S. TORRENT PHARMACEUTICALS LTD. (RESEARCH CENTRE), GUJARAT 91. M/S. TORRENT PHARMACEUTICALS LTD. (RESEARCH CENTRE), GUJARAT TEST LICENCE AMENDMENT TEST LICENCE APPROVAL APPROVAL TEST LICENCE CLARIFICATION APPROVAL 9746 AMENDMENT 8294 AMENDMENT AMENDMENT APPROVAL APPROVAL APPROVAL TEST LICENCE 92. M/S. TORRENT PHARMACEUTICALS CLARIFICATION
9 LTD., AHMEDABAD M/S. VEEDA CLINICAL RESEARCH PVT. 94. M/S. VEEDA CLINICAL RESEARCH PVT. 95. M/S. VEEDA CLINICAL RESEARCH PVT. 96. M/S. VEEDA CLINICAL RESEARCH PVT. 97. M/S. VEEDA CLINICAL RESEARCH PVT. 98. M/S. VEEDA CLINICAL RESEARCH PVT. 99. M/S. VIMTA LABS LTD., HYDERABAD M/S. WATSON PHARMA PVT. LTD., NAVI MUMBAI M/S. WATSON PHARMA PVT. LTD., NAVI MUMBAI M/S. WATSON PHARMA PVT. LTD., NAVI MUMBAI APPROVAL APPROVAL APPROVAL APPROVAL TEST LICENCE TEST LICENCE TEST LICENCE CLARIFICATION APPROVAL APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 06.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. VMG PHARMACEUTICALS PVT. LTD., C/O. M/S. AXA PARENTERALS LTD., DEHRADUN 26122 APPROVAL COSMETICS DIVISION S.NO.
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 01.07.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF LETTER 1. M/S. INSTERGY HEALTHCARE PVT. LTD, THANE 17866 DEFICIENCY LETTER 2. M/S. RP TELEBUY SKYSHOP PVT. LTD,
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 22.03.2016 BIOLOGICAL DIVISION S. NO. NAME OF COMPANY DY. NO. STATUS 1 M/S GLOBION INDIA PVT, LTD 2 M/S PANACEA BIOTECH LTD CLARIFICATION LETTER 989 CLARIFICATION LETTER 3 M/S VIMTA
TODAY LETTER DATED
TODAY DATED 08.05.2018 PERTAINING TO MISC S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. MEENAKSHI MISSION HOSPITAL & RESEARCH CENTRE 13542 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. IMAGING
Indian Pharmaceutical Industry
Colloquium on India s Growing Dependence on Imports in the area of Bulk Drugs Indian Pharmaceutical Industry Public Health Foundation of India 23 rd December, 2014 Pharma Industry and Market in India The
Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V
Current Status of Pharmaceutical Patenting at United States Patent Office Rau. B. S Appaji P. V Abstract: Indian pharmaceutical industry has proved manufacture of global quality pharmaceutical products
Pharmaceutical Reviews Year: 2008 Vol: 6 Issue: 1 ISSN: School of Pharmacy and Technology Management, NMiMS University, Mumbai
Dayanidhi B, Amol S School of Pharmacy and Technology Management, NMiMS University, Mumbai The US$65-billion (in 2005), global R&D pie is expected to grow to US$l00-billion by 2010. If India secures even
Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms. The Open University, Milton Keynes. Kalpana Chaturvedi Jan 17, 2007
Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms The Open University, Milton Keynes Kalpana Chaturvedi Jan 17, 2007 Agenda Policy Market Research Opportunities Patent regimes
Pharmaceutical. Indian. Industry. Steel. otel. Pesticides. oal. nking Express Service. The. Banking. Power Generation Pa.
inum Banking Cement Commercial Vehicle omponent Business Process Management (BPM) arel Chlor-Alkali Natural Gas anganese Ore ight Transport oal otel Pesticides Cotton & Cotton Ya Construction CRAMS Crude
Indian Pharma Global Impact
Indian Pharma Global Impact IIT Alumni Japan Conference Nov 15-17,Tokyo Satish Reddy Managing Director Dr. Reddy s Laboratories Ltd 1 Headlines: TODAY More than three-quarters of the Top 50 pharma companies
Date of Applicati on. Status (indicating whether the file is under process / Query issued / Pending at the Firm s end
Pendency of CT NOC (Year) S. N o Name of the drug 1 Test the bioequivalenc e tween Biphasic Isophane insulin (Consegna) and Wosulin N 2 Test for Bioequivalenc e tween Consegna (Isophane insulin human suspension
Leading domestic players in India s pharmaceutical market in 2015
THE INDIAN PHARMACEUTICAL MARKET LEADING DOMESTIC COMPANIES 2015 Leading domestic players in India s pharmaceutical market in 2015 1 Executive Summary 1.1 Executive Summary 1.2 Research and Analysis Methods
Industry Overview
Biotech Directory Industry Overview 2009-10 SURVEY & RANKING METHODOLOGY BioSpectrum conducted this survey jointly with the Association of Biotechnology Led Enterprises (ABLE). BioSpectrum and ABLE have
Minutes of the Policy Relaxation Committee Meeting held under the Chairmanship of DGFT, Shri Pravir Kumar, IAS on
Minutes of the Policy Relaxation Committee Meeting held under the Chairmanship of DGFT, Shri Pravir Kumar, IAS on 16.09.2014 Meeting No. 09/AM15 held on 16.09.2014 at 11.00 A.M. List of officers present
Abbott Acquisition of Piramal s Healthcare Solutions Business
Abbott Acquisition of Piramal s Healthcare Solutions Business May 21, 2010 GDS_70000_Title_v1 1 The Pharmaceutical Market in India India Overview 1.1BN people; 2nd largest workforce in the world 2nd fastest-growing
ROLE OF RELIANCE, RE-ENGINEERING, AND REGIONALIZATION IN THE OPTIMIZATION OF REGULATORY SYSTEMS
ROLE OF RELIANCE, RE-ENGINEERING, AND REGIONALIZATION IN THE OPTIMIZATION OF REGULATORY SYSTEMS Murray M. Lumpkin, M.D., M.Sc. Lead for Global Regulatory Systems Initiatives Bill and Melinda Gates Foundation
Twenty Years of TRIPS Agreement: What Difference Did Product Patent Protection Make to the Pharmaceutical Industry in India?
Twenty Years of TRIPS Agreement: What Difference Did Product Patent Protection Make to the Pharmaceutical Industry in India? Sudip Chaudhuri Indian Institute of Management Calcutta International Workshop
SUPERGENERICS BIOSIMILARS Biosimilars (Continued) TABLE 3 BIOLOGICS FACING THE LAUNCH OF BIOSIMILARS,
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 2 MARKET ANALYSES AND FORECASTS... 2 METHODOLOGY... 2 INTENDED AUDIENCE... 3 INFORMATION
Minutes of the Policy Relaxation Committee Meeting held under the Chairmanship of DGFT, ShriPravir Kumar, IAS on
Minutes of the Policy Relaxation Committee Meeting held under the Chairmanship of DGFT, ShriPravir Kumar, IAS on 30.12.2014 Meeting No. 16/AM15 held on 30.12.2014 at 11.30 A.M. List of officers present
Pharmaceutical. Indian. Industry. Steel. otel. Pesticides. oal. nking Express Service. The. Banking. Power Generation Pa.
inum Banking Cement Commercial Vehicle omponent Business Process Management (BPM) arel Industry Chlor-Alkali Natural Gas anganese Ore ight Transport oal otel Pesticides Cotton & Cotton Ya Construction
Selected References - India
Selected References - India Industry Customer Location UCRETE Grade Area of use Chemicals/Refining/Textiles BASF India Mangalore UD200, MF Polymer synthesis area Birla Cellulosic Kosamba MF Processing
Industry Perspective
CII - 12 th National Pharmaceutical Conclave 2014 Industry Perspective by D G Shah Secretary General Indian Pharmaceutical Alliance New Delhi 12 December 2014 1 Industry Perspective Outline of Presentation
HEALTHCARE PRICING IN INDIA THE IMPACT OF DOCTOR- HOSPITAL DYNAMICS Monika Sood & Dr. Rohan Desai
HEALTHCARE PRICING IN INDIA THE IMPACT OF DOCTOR- HOSPITAL DYNAMICS Monika Sood & Dr. Rohan Desai 1 Pricing in healthcare is driven by a number of factors: local market dynamics, affordability and consumer
NOTICE INVITING TENDER FOR SUPPLY OF MEDICINES / SURGICAL ITEMS TO KOIRA REGION DURING THE YEAR
THE ODISHA MINING CORPORATION LIMITED (A Gold Category State PSU) OFFICE OF THE REGIONAL MANAGER At/P.O.-Koira, Dist.-Sundargarh-770048 Ph. No.- 06625-235301, 235304, Fax : 06625-235228 NIT No- 01/OMC/ROK/2016
The Netherlands Inspected Non-domestic Test Facilities Status 31 July 2013 Report issued 6 August 2013 Health Care Inspectorate
The Netherlands Inspected Non-domestic Test Facilities Status 31 July 2013 Report issued 6 August 2013 Health Care Inspectorate TEST FACILITY DATE OF INSPECTION STATUS NATURE OF INSPECTION AREA OF EXPERTISE
JAS INDIA People Make The Difference
JAS INDIA 2016 People Make The Difference 2005-2016 Evolution of JAS India People Make The Difference JAS INDIA Operational September 2005 Core Business International Air and Ocean Freight Forwarding Market
BioIndia News / Updates
BioIndia News / Updates Free, bi-monthly newsletter for India s BioBusiness, BioScience, Regulatory and Clinical News; tracking news/trends in the India biopharmaceutical/pharmaceutical biologics industry
Odisha Mining Corporation Limited (A GOLD CATEGORY STATE PSU)
Odisha Mining Corporation Limited (A GOLD CATEGORY STATE PSU) CORRIGENDUM The time period of receipt of bids of the NIT No.03/OMC/ROK/2016 for supply of medicines/surgical items to our dispensaries at
INDIA PUBLIC: PRIVATE PARTNERSHIP MODELS FOR R&D (INFECTIOUS DISEASES) OPPORTUNITIES AND CONSTRAINTS
PUBLIC: PRIVATE PARTNERSHIP MODELS FOR R&D (INFECTIOUS DISEASES) OPPORTUNITIES AND CONSTRAINTS Prof. V.K.Vinayak Senior Advisor Department of Biotechnology Ministry of Science & Technology Block # 2, CGO
intgeni energy solutions pvt. Ltd
intgeni energy solutions pvt. Ltd About us Intgeni energy solutions pvt. ltd. (iespl) is a privately held company based in Mumbai that provides solutions with cutting edge technology products in the Energy
The rays of growth spread as the vision is clear. Think... Challenge... Explore... Create... Exceed...
The rays of growth spread as the vision is clear Who we are Almost 25 years ago, the Indian Pharmaceu cal Industry began to understand the benefits of following Good Manufacturing Prac ce guidelines (commonly
BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3
BIO OUTSOURCING ASIA Biopharmaceutical Outsourcing Opportunities and Challenges SEPTEMBER 2008 VOL. 1 ISSUE 3 Bio Outsourcing Asia TABLE OF CONTENTS September 2008 Vol. 1 Issue 3 CanBiotech Inc. CHINA
PHARMACY TO THE WORLD
Cover Story 8 PHARMACY TO THE WORLD India is emerging as a major global pharmaceuticals hub, attracting international drug giants who are keen to set up research and development (R&D) labs and other facilities
Indian Pharmaceutical Industry: Overcoming Hurdles And Opening Up New Opportunities
November 02, 2012 Indian Pharmaceutical Industry: Overcoming Hurdles And Opening Up New Opportunities Manu Jaggi, Ph.D Vice President Dabur Research Foundation 22, Site IV, Sahibabad Ghaziabad 201010 Uttar
Clinical Trials Registry and Good Clinical Practice: an Indian Scenario
Additional Professor, & Joint Medical Superintendent, Department of Pharmacology, Postgraduate Institute of Medical Education Research, Chandigarh 160012, India Chandigarh 160012, India Clinical Trials
Opportunities in the India Biopharma Sector
Opportunities in the India Biopharma Sector October 2011 Anil Vaidya-Sector Specialist Life science Team UK Trade & Investment Source: Ingram Publishing/the Agency Collection/Getty Images The India Conundrum?
For updated information, please visit April 2018
PHARMACEUTICALS April 2018 Table of Content Executive Summary...3 Advantage India......4 Market Overview...6 Porters Five Forces Analysis......17 Recent trends and Strategies..... 18 Growth Drivers...24
For updated information, please visit January 2018
PHARMACEUTICALS January 2018 Table of Content Executive Summary...3 Advantage India......4 Market Overview...6 Porters Five Forces Analysis......17 Recent trends and Strategies..... 18 Growth Drivers...24
For updated information, please visit March 2018
PHARMACEUTICALS March 2018 Table of Content Executive Summary...3 Advantage India......4 Market Overview...6 Porters Five Forces Analysis......17 Recent trends and Strategies..... 18 Growth Drivers...24
Executive Summary. 6. The table below illustrates the companies which were covered under this project:
Executive Summary 1. The project entitled 'Success Stories of Drugs & Pharmaceuticals, Biotechnology and Process Engineering Industry was awarded to GESS to document the success and lessons learnt of identified
Pharmaceutical Market: India A Comprehensive Industry Analysis
Pharmaceutical Market: India A Comprehensive Industry Analysis Kelly Scientific Publications 2013 Table of Contents 1.0 Summary 10 1.1 Objectives of Report 10 1.2 Scope of Study 11 1.3 Data Sources and
Opening Remarks of the Chairperson. Decisions
Decisions taken in the 44 th Meeting of the Genetic Engineering Approval Committee (GEAC) held on 14 th July 2004. Opening Remarks of the Chairperson The Chairperson explained that as per the guidelines
Government of India Ministry of Environment, Forest & Climate Change (HSM Division)
Government of India Ministry of Environment, Forest & Climate Change (HSM Division) Agenda for 67 th Meeting of Expert Committee for Appraisal of Proposals for Import/Export of Hazardous and Other Wastes
Government of India Ministry of Environment, Forest & Climate Change (HSM Division)
Government of India Ministry of Environment, Forest & Climate Change (HSM Division) Agenda for 73 rd Meeting of Expert Committee for Appraisal of Proposals for Import/Export of Hazardous and Other Wastes
Regulations of in-vitro Diagnostic Kits & Role of NIB in Testing
Regulations of in-vitro Diagnostic Kits & Role of NIB in Testing DR. REBA CHHABRA HEAD DIAGNOSTIC DIVISION NATIONAL INSTITUTE OF BIOLOGICALS,NOIDA (MINISTRY OF HEALTH & FAMILY WELFARE) GOVERNMENT OF INDIA
AGENDA NO.2.1 : IMPORT OF ELECTRICAL AND ELECTRONIC ASSEMBLIES ETC.
Decision of 81 st Meeting of the Expert Committee (EC) for Appraisal of Proposals for Import/Export of Hazardous and Other Wastes held on 17 th and 18 th August 2017 in the Ministry Agenda for the 17 th
Piramal Enterprises Limited. Pharma Investor Presentation March 2017
Piramal Enterprises Limited Pharma Investor Presentation March 2017 Pharma business portfolio with strong presence both within and outside India Piramal Pharma 9MFY17 Rev: Rs.2,679 Crores Global Pharma
Snapshot - Indian Pharma Industry. Indian Pharmaceutical Market ~US $ 18bn Import ( )US$ 2.7 Bn
Presentation By Debasish Panda Joint Secretary Ministry of Health & Family Welfare Government of India DRUG REGULATORY FRAMEWORK & NEW INITIATIVES INDIA Snapshot - Indian Pharma Industry Indian Pharmaceutical
19 th SEC- (Antimicrobial, antiparasitic& antifungal, antiviral) meeting held on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi
19 th SEC- (Antimicrobial, antiparasitic& antifungal, antiviral) meeting held on 22-06- 2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 Recommendation:- The 19th SEC (Antimicrobial, antiparasitic&
Job Fair UDAAN-2016 organized by SRKSM Venue: Anand Pharmacy College, Anand , Thursday.
Report of Job Fair UDAAN-2016, held at Anand Pharmacy College, on 07-04-2016 No. of Pharma Employer Participated: 09 No. of Students Registered: 46 (B. Pharm.: 08 + M. Pharm: 38) No. of Shortlisted Students:
Indian Pharmaceutical Industry: An Overview
IOSR Journal Of Humanities And Social Science (IOSR-JHSS) Volume 13, Issue 3 (Jul. - Aug. 2013), PP 51-66 e-issn: 2279-0837, p-issn: 2279-0845. www.iosrjournals.org Indian Pharmaceutical Industry: An Overview
CRGO SILICON STEEL. CRGO Silicon Steel products. Our quality, your reliability. Manufacturer & Exporter of
CRGO SILICON STEEL Manufacturer & Exporter of CRGO Silicon Steel products Our quality, your reliability JAYBEE Laminations Pvt. Ltd. was established in 1988 as a manufacturer of CRGO Silicon steel cores
Facilitating crisis response processes and strategic decision making at Transocean
re-imagining offices Facilitating crisis response processes and strategic decision making at Transocean Dealing with crisis situations is an every-day possibility in deep-sea drilling scenarios that Transocean
REVIEW AND COMPARISON OF SALES LEVEL CRM PRACTICES IN PHARMACEUTICAL COMPANIES AS PER CUSTOMER TYPE
Inspira-Journal of Commerce, Economics & Computer Science (JCECS) 355 ISSN : 2395-7069 General Impact Factor : 2.0546, Volume 03, No. 04, Oct.-Dec., 2017, pp. 355-363 REVIEW AND COMPARISON OF SALES LEVEL
The New Indian Patent Law: Will it harm or heal?
The New Indian Patent Law: Will it harm or heal? Professor Prabuddha Ganguli (PhD) CEO VISION-IPR & Adjunct Professor, School of Humanities, Indian Institute of Technology, Bombay, India. 103 B SENATE,
For updated information, please visit June 2018
PHARMACEUTICALS June 2018 Table of Content Executive Summary...3 Advantage India......4 Market Overview...6 Recent trends and Strategies..... 14 Growth Drivers...18 Opportunities..... 28 Useful Information.....30
Corporate Social Responsibility Policy of Siemens Limited (SL)
Corporate Citizenship Corporate Social Responsibility Policy of Siemens Limited (SL) Recommended by: Corporate Social Responsibility Committee of Siemens Ltd Prepared date: 22 nd November 2016 Version
WORKING CAPITAL MANAGEMENT: A STUDY ON INDIAN PHARMA COMPANIES
ISSN (Print): 30-5504 ISSN (Online): 347-4793 WORKING CAPITAL MANAGEMENT: A STUDY ON INDIAN PHARMA COMPANIES Sri Ayan Chakraborty Faculty: Management: University Program (Techno India University), ICA
Influence of Research and Development (R&D) Cost on Profitability: A Study of Indian Pharmaceutical Sector
IOSR Journal of Economics and Finance (IOSR-JEF) e- ISSN: 2321-5933, p-issn: 2321-5925. Volume 9, Issue 2 Ver. II (Mar-Apr.2018), PP 63-68 www.iosrjournals.org Influence of Research and Development (R&D)
I N V I T A T I O N. Key Technologies to Address Bioprocess Challenges. 8 BioConclave 2013 VENUE & DATE HYDERABAD PUNE AHMEDABAD. Vaccine World Summit
th 8 BioConclave 2013 Key Technologies to Address Bioprocess Challenges HYDERABAD March 1, 2013 HOTEL MARRIOTT VENUE & DATE AHMEDABAD March 4, 2013 COURTYARD BY MARRIOTT PUNE March 7, 2013 WESTIN HOTEL
For updated information, please visit May 2018
PHARMACEUTICALS May 2018 Table of Content Executive Summary...3 Advantage India......4 Market Overview...6 Porters Five Forces Analysis......14 Recent trends and Strategies..... 15 Growth Drivers...20
Opportunities unfurling
Opportunities unfurling 10 February 2003 News Image not found or type unknown On 1 January 1995 India became a signatory to World Trade Organisation (WTO). India agreed to implement a product patent regime
Client List, Macro Assignments Events / Business Meets
Client List, Macro Assignments Events / Business Meets 1. Industrial Development Bank of India Limited 5 th Floor, IDBI Tower, WTC Complex, Cuffe Parade, Mumbai 400 005, Maharashtra Ph : (022)5655 2389
1. Dr. Jagdish Prasad, Chairman Director General of Health Services, Nirman Bhawan, New Delhi.
MINUTES OF THE 73 rd MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 01 st AUGUST, 2016 AT DGHS, NIRMAN BHAWAN, NEW DELHI PRESENT 1. Dr. Jagdish Prasad, Chairman Director General of Health Services,
Building Biotech Technology Transfer Opportunities
HEALTHCARE Building Biotech Technology Transfer Opportunities Sponsor and developer strategies for success By Alison Sahoo Alison Sahoo Alison Sahoo is a pharmaceutical industry analyst with more than
For updated information, please visit October 2017
PHARMACEUTICALS October 2017 Table of Content Executive Summary...3 Advantage India......4 Market Overview....6 Porters Five Forces Analysis......15 Recent trends and Strategies..... 16 Growth Drivers...21
April 13, Dear Sir or Madam:
April 13, 2016 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane Room 1061 Rockville, MD 20852 Re: DOCKET Nos. FDA-2015-P-5022
File no Name of firm Recommendations. Dr. Neena Khanna, AIIMS
Recommendation:- The 9 th SEC-(Dermatology & Allergy) deliberated the proposals on 22.12.2014 and recommended the following:- Agenda no. File no Name of firm Recommendations 1 12-34/14-DC Isotretinoin
Opening Remarks of the Chairman
Decisions taken in the 45 th Meeting of the Genetic Engineering Approval Committee (GEAC) held on 11 th August 2004. Opening Remarks of the Chairman At the outset, the Chairman welcomed all the members.
Darshit S. Patel, IJPSR, 2012; Vol. 3(12): ISSN: FDA WARNING LETTER ANALYSIS: A TOOL FOR GMP COMPLIANCE. Darshit S.
IJPSR (2012), Vol. 3, Issue 12 (Review Article) Received on 20 August, 2012; received in revised form 28 September, 2012; accepted 20 November, 2012 FDA WARNING LETTER ANALYSIS: A TOOL FOR GMP COMPLIANCE
Patents & Health. Dr. Brian W Tempest.
Patents & Health Dr. Brian W Tempest www.briantempest.com Seminar on the Relationship between Patent Systems and the Availability of Medicines in Developing Countries and Least Developed Countries World
Plant : Plot #Z-1 & Z-83, C/o. Dahej SEZ Ltd., P 0. Dahej, Taluka Vagra, Dist. Bharuch
Individual commitment with redefining one s own IMPOSSIBLE to a group effort is what has defined the team work at OPaL. It is this synergy and coherence that has shaped the megalith as it stands today,
Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP
Regulations & Guidelines Specific to Ethics Schedule Y & CDSCO-GCP Dr. K. Bangarurajan M Pharm, PhD Deputy Drugs Controller (India) CDSCO West Zone Outline Licensing Authority India - Clinical Trial: CDSCO
VASUDHA PHARMA CHEM LIMITED, Hyderabad, India
, Hyderabad, India USFDA accepted facility Korean FDA inspected Mexican MoH - GMP certified WHO-GMP certified , Hyderabad, India Contributing to affordable healthcare Head office : Vasudha Pharma Chem
MONTHLY DOSE AUGUST 2018
MONTHLY DOSE AUGUST 2018 News for the Month Company Cipla s Uganda arm plans IPO, listing Sun Pharma recalls over 5.2k units of testosterone cypionate injections from US Sun Pharma gains on launching novel
EXPRESSION OF INTEREST
EXPRESSION OF INTEREST Selection of Retail Pharmacy Chain (s) for supply of medicines to employees/ beneficiaries of BHEL Retired Employees Contributory Health Scheme DISCLAIMER All information contained
What teams demand today?
What teams demand today? INTER ACTION! The ability of people to INTER ACT! and deliver results faster is a critical determinant in today s business and decision making. INTER ACTION! adds life to discussions,
For updated information, please visit July 2017
PHARMACEUTICALS July 2017 Table of Content Executive Summary...3 Advantage India......4 Market Overview....6 Porters Five Forces Analysis......15 Recent trends and Strategies..... 16 Growth Drivers...21
1 st National Biotechnology Conclave 2017 Strengthening the Biotech Ecosystem in India 22 December 2017: Hotel Le Meridien, New Delhi.
Program Grid 22 December 2017 Page 0830-1000 Registration & Networking Tea/Coffee 1000-1100 Inaugural Session 1 1100-1200 Panel Discussion I: Way forward for the Vaccine industry 2 1200-1300 Panel discussion
Water & Waste Management System
Water & Waste Management System High Purity Water Treatment Storage And Distribution System Pharmaceutical Equipments & Ancillaries Turnkey Projects in Process & Utility Piping Sea Water Desalination Plant
GDUFA Past & Present
GDUFA Past & Present David R. Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory Affairs Generic Pharmaceutical Association June 15, 2015 About GPhA GPhA represents the manufacturers and distributors
EMERGENCE OF INDIA AS THE PHARMACY OF THE WORLD: CONVERGENCE OF PUBLIC POLICY, INDUSTRY, SCIENCE AND TECHNOLOGY
EMERGENCE OF INDIA AS THE PHARMACY OF THE WORLD: CONVERGENCE OF PUBLIC POLICY, INDUSTRY, SCIENCE AND TECHNOLOGY Workshop on Scientific Achievements of Independent India An Historical Approach Indian Institute
Join us and benefit from our efforts towards Connecting the dots in Life Sciences sector to propel growth!
In Patnership with: February 8-10, 2016, Hyderabad, India. Join us and benefit from our efforts towards Connecting the dots in Life Sciences sector to propel growth! Connecting the dots February 8-10,
INDIAN PHARMACEUTICAL INDUSTRY IN THE NEW PARADIGM
INDIAN PHARMACEUTICAL INDUSTRY IN THE NEW PARADIGM Tapan Ray Director General Organisation of Pharmaceutical Producers of India 2010 Health & Youth Conference, South Korea 15 th April, 2010 Content India
GLOBAL MARKETS FOR DRUG REPURPOSING
GLOBAL MARKETS FOR DRUG REPURPOSING PHM175A January 2016 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-202-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
Where Indian Pharma Corporates Stand Study With Reference To Corporate Governance Practices and CSR
Indian Journal of Science and Technology, Vol 8(S4), 76 82, February 2015 ISSN (Print) : 0974-6846 ISSN (Online) : 0974-5645 DOI:.17485/ijst/2015/v8iS4/60359 Where Indian Pharma Corporates Stand Study
AN UPDATE ON INDIAN BIOSAFETY REGULATORY SYSTEM. Dr. Vibha Ahuja Biotech Consortium India Limited
AN UPDATE ON INDIAN BIOSAFETY REGULATORY SYSTEM Dr. Vibha Ahuja Biotech Consortium India Limited STRUCTURE OF PRESENTATION 1. Existing regulatory framework in India 2. New Acts/policies dealing with GM
GCI/ T&D/Training Catalogue - 1 -
- 1 - ABOUT US We are leading ISO 9001:2000 Certified Engineering Organization in the field of Environment, Safety, Health & Hygiene, Risk-Engineering & Quality Systems, having Business Operations in India,
Perspective on China and India as Rapidly Evolving Sources of Biotech Products
Perspective on China and India as Rapidly Evolving Sources of Biotech Products The Japanese Biologics Forum February 16, 2007 Gene Murano, Ph.D. Vice President R.Q.C. Strategic Operations Genentech, Inc.
38 th Technical Committee Meeting
MINUTES OF 38 th MEETING OF THE TECHNICAL COMMITTEE HELD ON 22.12.2016 UNDER THE CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE
Indian CRAMS players to cram in growth: CARE Ratings
January, 2015 Credit Perspective : Indian CRAMS Indian CRAMS players to cram in growth: CARE Ratings CARE Ratings expects Indian Contract Research and Manufacturing Services (CRAMS) players to register
May 14, 2014 CGI Announces Acquisition of BioServe India
Empowering Personalized Cancer Treatment May 14, 2014 CGI Announces Acquisition of BioServe India CGI and BioServe India Enter Into Acquisition Agreement On May 14 th, 2014 Cancer Genetics, Inc. and BioServe
Minutes of the Policy Relaxation Committee Meeting held under the Chairmanship of Shri Pravir Kumar, DGFT on 09/06/2015
Minutes of the Policy Relaxation Committee Meeting held under the Chairmanship of Shri Pravir Kumar, DGFT on 09/06/2015 Meeting No. 04/AM16 held on 09/06/2015 and 10/06/2015 at 11:00. List of officers
Sr No Billers Credit Card Donations Electricity Page 1
Sr No Billers Credit Card 1 Amex Card 2 Axis Bank Credit Card 3 Citibank Credit Card 4 ICICI Credit Card 5 IndusInd Bank Credit Card 6 Ratnakar Bank Credit Card 7 SBICARD Donations 8 AID INDIA 9 Childline
TAIWAN. Who Should Attend? Endless Potential & Opportunities. Where innovations are shaping a new era of intelligent healthcare.
TAIWAN Where innovations are shaping a new era of intelligent healthcare World-class medical centers and hospitals Over 1800 biotech companies Best healthcare system in the world Top-ranked life science
A Comparative Study of Profitability of Selected Pharma Companies of India
A Comparative Study of Profitability of Selected Pharma Companies of India Dr.Bhavik U.Swadia 1 1 Assistant Professor, S.M.Patel Institute of Commerce, GLS University, India Correspondence: Dr.Bhavik U.Swadia,
File no./drug Name Name of firm/ Institute Recommendations. M/s. AstrazenecaPharma India Limited
Recommendations: I agree the minutes of 51 st SEC-Oncology & Haematology meeting held on 21.03.2017 at CDSCO HQ New Delhi Agenda File /Drug Name Name of firm/ Institute Recommendations New Drugs Division
Partnering For Your Success... Always.
Partnering For Your Success... Always. RSM Astute Consulting Group Indian member of RSM International Personnel strength of over 1,200 RSM International World s 7th largest network of independent audit,
Decision of the 91 st Meeting of the Expert Committee held on 26 th September, 2018
Decision of the 91 st Meeting of the Expert Committee held on 26 th September, 2018 AGENDA NO. 2.1: IMPORT OF ELECTRICAL AND ELECTRONIC ASSEMBLIES ETC. 2.1.1 M/s Intel Technology India Pvt. Ltd., Bangalore,
Constructed Geological Filter system: Green ways for Zero Liquid Discharge
5 th INDUSTRIAL GREEN CHEMISTRY WORLD (IGCW 2017) CONVENTION & ECOSYSTEM Emerging Tools, Technologies & solutions Zero Discharge Approach Constructed Geological Filter system: Green ways for Zero Liquid